Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher L Case

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Plos Pathogens|December 2, 2008
Type IV secretion-dependent activation of host MAP kinases induces an increased proinflammatory cytokine response to Legionella pneumophilaSunny Shin, Christopher L Case, Kristina A Archer, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 12, 2013
Caspase-11 stimulates rapid flagellin-independent pyroptosis in response to Legionella pneumophilaChristopher L Case, Lara J Kohler, Jonilson B Lima, et al.
ACS Nano|December 19, 2014
Triggering of RNA interference with RNA-RNA, RNA-DNA, and DNA-RNA nanoparticlesKirill A Afonin, Mathias Viard, Ioannis Kagiampakis, et al.
Nucleic Acids Research|November 7, 2013
Co-transcriptional production of RNA-DNA hybrids for simultaneous release of multiple split functionalitiesKirill A Afonin, Ravi Desai, Mathias Viard, et al.
The Lancet. Infectious Diseases|May 14, 2022
Safety and immunogenicity of a trivalent virus-like particle vaccine against western, eastern, and Venezuelan equine encephalitis viruses: a phase 1, open-label, dose-escalation, randomised clinical trialEmily E Coates, Srilatha Edupuganti, Grace L Chen, et al.
Nature Medicine|February 4, 2022
Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trialKatherine V Houser, Grace L Chen, Cristina Carter, et al.
Eclinicalmedicine|July 5, 2022
Safety and immunogenicity of an HIV-1 prefusion-stabilized envelope trimer (Trimer 4571) vaccine in healthy adults: A first-in-human open-label, randomized, dose-escalation, phase 1 clinical trialKatherine V Houser, Martin R Gaudinski, Myra Happe, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Plos Pathogens|December 2, 2008
Type IV secretion-dependent activation of host MAP kinases induces an increased proinflammatory cytokine response to Legionella pneumophilaSunny Shin, Christopher L Case, Kristina A Archer, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 12, 2013
Caspase-11 stimulates rapid flagellin-independent pyroptosis in response to Legionella pneumophilaChristopher L Case, Lara J Kohler, Jonilson B Lima, et al.
ACS Nano|December 19, 2014
Triggering of RNA interference with RNA-RNA, RNA-DNA, and DNA-RNA nanoparticlesKirill A Afonin, Mathias Viard, Ioannis Kagiampakis, et al.
Nucleic Acids Research|November 7, 2013
Co-transcriptional production of RNA-DNA hybrids for simultaneous release of multiple split functionalitiesKirill A Afonin, Ravi Desai, Mathias Viard, et al.
The Lancet. Infectious Diseases|May 14, 2022
Safety and immunogenicity of a trivalent virus-like particle vaccine against western, eastern, and Venezuelan equine encephalitis viruses: a phase 1, open-label, dose-escalation, randomised clinical trialEmily E Coates, Srilatha Edupuganti, Grace L Chen, et al.
Nature Medicine|February 4, 2022
Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trialKatherine V Houser, Grace L Chen, Cristina Carter, et al.
Eclinicalmedicine|July 5, 2022
Safety and immunogenicity of an HIV-1 prefusion-stabilized envelope trimer (Trimer 4571) vaccine in healthy adults: A first-in-human open-label, randomized, dose-escalation, phase 1 clinical trialKatherine V Houser, Martin R Gaudinski, Myra Happe, et al.
Pageof 2